BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2473574)

  • 1. [Benign prostatic hyperplasia].
    Bauer HW; Sudhoff F; Dressler S
    Wien Med Wochenschr; 1989 May; 139(10):229-34. PubMed ID: 2473574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benign prostatic hyperplasia as a frequent senile disease of the male].
    Rassler J; Dieterich F
    Z Gesamte Inn Med; 1988 May; 43(10):273-9. PubMed ID: 2457994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of benign prostatic hyperplasia syndrome. 2: Interventional therapy].
    Muschter R; Hofstetter A
    MMW Fortschr Med; 2000 Jan; 142(3 Suppl):161-9. PubMed ID: 10783606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of benign prostatic hyperplasia].
    Harzmann R; Weckermann D; Wawroschek F
    Z Arztl Fortbild Qualitatssich; 1998 Jun; 92(5):319-24. PubMed ID: 9702820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia--choice of therapy in the elderly].
    Schultze-Seemann W
    Fortschr Med; 1993 Sep; 111(25):394-7. PubMed ID: 7691697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern approach to conservative treatment of benign prostatic hyperplasia].
    Marusić G; Stojić S; Stojkov J
    Med Pregl; 1997; 50(11-12):535-8. PubMed ID: 9471517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia.
    Barry M; Roehrborn C; Webber R
    Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of transurethral resection of the prostate and medical treatment for the patient with moderate symptoms of benign prostatic hyperplasia.
    Yamamoto M; Hibi H; Miyake K
    Nagoya J Med Sci; 1996 Mar; 59(1-2):11-6. PubMed ID: 8725483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.
    Garraway WM; Russell EB; Lee RJ; Collins GN; McKelvie GB; Hehir M; Rogers AC; Simpson RJ
    Br J Gen Pract; 1993 Aug; 43(373):318-21. PubMed ID: 7504499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic hyperplasia: conservative treatment].
    Bartsch G
    Urologe A; 1989 Nov; 28(6):305. PubMed ID: 2481354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transurethral thermotherapy of the prostate--a very promising treatment method for benign prostatic hyperplasia].
    Stoffel F; Gasser TC; Blöchlinger A; Mattarelli G; Rutishauser G
    Praxis (Bern 1994); 1997 Sep; 86(36):1373-7. PubMed ID: 9381031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.